Skip to main content

Table 1 Study characteristics of participants and study associations

From: Ocular complications in HIV positive patients on antiretroviral therapy in Ghana

Characteristics Number of participants, n (%) Number with HIV-related ocular complications, n (%) p-value*
Age group (years) 20 ≤ 30 16 7 (15) 0.005
31 ≤ 45 60 27 (56)
>45 24 14 (29)
Gender Male 32 15 (31) 0.479
Female 68 33 (69)
HIV Type 1 90 42 (88) 0.074
2 7 5 (10)
1&2 3 1 (2)
WHO Clinical Staging 1 2 2 (4) <0.001
2 23 8 (17)
3 72 37 (77)
4 3 1 (2)
Ranges of CD4+ T Counts (cells/μL) 0 ≤ 200 36 24 (50) 0.001
201 ≤ 500 46 14 (29)
> 500 18 10 (21)
Adherence to Treatment Regular 74 21 (44) 0.001
Irregular 3 3 (6)
Defaulting 23 24 (50)
Antiretroviral Regimen 1st choice 75 40 (83) <0.001
2nd choice 25 8 (17)
  1. *Significant at 5 %; 1st choice ARV regimen – Zidovudine + Lamivudine + Nevirapine/ Efavirenz; 2nd choice ARV regimen – Tenofovir + Lamivudine + Nevirapine/ Efavirenz; ≤ Less than or equal to; ≥ More than or equal to; > More than; < Less than